Acceptability and User Perceptions of Artificial Intelligence-based Mobile Applications Adoption for Weight Management: A Sequential Explanatory Study
Sponsor
National University Health System, Singapore (Other)
Overall Status
Recruiting
CT.gov ID
NCT05257239
Collaborator
(none)
600
1
16.4
36.7
Study Details
Study Description
Brief Summary
To understand the user perceptions of AI and non-AI-based mobile apps for weight management in people with overweight and obesity.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
600 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Acceptability and User Perceptions of Artificial Intelligence-based Mobile Applications
Actual Study Start Date
:
Feb 17, 2022
Anticipated Primary Completion Date
:
Feb 17, 2023
Anticipated Study Completion Date
:
Jun 30, 2023
Outcome Measures
Primary Outcome Measures
- Unified Theory of Acceptance and Use of Technology 2 (UTAUT2) [2021-2023]
Secondary Outcome Measures
- Qualitative interviews [2021-2023]
Eligibility Criteria
Criteria
Ages Eligible for Study:
21 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
- Participants will be recruited if they are above 21 years old, have a BMI ≥23kg/m2 and understand English language.
Exclusion Criteria:
- There will be no exclusion criteria to maximize representation of the general population of Singaporean who are overweight and obese.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | National University of Singapore | Singapore | Singapore | 117597 |
Sponsors and Collaborators
- National University Health System, Singapore
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Jocelyn Chew,
Research Fellow,
National University Health System, Singapore
ClinicalTrials.gov Identifier:
NCT05257239
Other Study ID Numbers:
- 2021/00834
First Posted:
Feb 25, 2022
Last Update Posted:
Feb 25, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: